• # LGM Pharma is a Probucol CAS# 23288-49-5 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Probucol
  • CAS #: 23288-49-5
  • Mode of Action:

    Probucol lowers serum cholesterol by increasing the fractional rate of low-density lipoprotein (LDL) catabolism in the final metabolic pathway for cholesterol elimination from the body. Additionally, probucol may inhibit early stages of cholesterol biosynthesis and slightly inhibit dietary cholesterol absorption. Recent information suggests that probucol may inhibit the oxidation and tissue deposition of LDL cholesterol, thereby inhibiting atherogenesis. It appears to inhibits ABCA1-mediated cellular lipid efflux.

  • Pharmacodynamics:

    Probucol lowers the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism. Additionally, probucol may inhibit cholesterol synthesis and delay cholesterol absorption. Probucol is a powerful antioxidant drug normally used to prevent vascular disease caused by the free radicals in the body.

  • IUPAC: 2, 6-di-tert-butyl-4-({2-[(3, 5-di-tert-butyl-4-hydroxyphenyl)sulfanyl]propan-2-yl}sulfanyl)phenol
  • ATC: C10AX02
  • PubChem: 4912
  • DrugBank: DB01599
  • Formula: C21H30O2
  • Molecular Mass: 516.842
  • Synonyms: 4,4'- (Isopropylidenedithio)bis(2, 6-di-tert-butylphenol) 4,4'-(Isopropylidenedithio)bis(2, 6-di-tert-butylphenol) 4,4'-(Isopropylidenedithio)bis(2,6-di-tert-butylphenol) 4,4'-(Isopropylidenedithio)bis[2, 6-di-tert-butylphenol] Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole Acetone, bis (3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole Acetone, bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole Probucolum [inn-latin]
  • SMILES: CC(C)(SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C
  • AHFS Code: 24:06.9
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants


  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service